IDT Biologika granted up to $36m to advance priority MERS vaccine 27-Aug-2018 By Maggie Lynch The Coalition for Epidemic Preparedness Innovations announced a collaboration with IDT Biologika for MERS vaccine development in which IDT will receive up to $36m.